Research output per year
Research output per year
Search results
-
2024
Corrigendum: First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP: TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors (Frontiers in Oncology, (2024), 14, (1376551), 10.3389/fonc.2024.1376551)
Shimizu, T., Powderly, J., Abdul Razak, A., LoRusso, P., Miller, K. D., Kao, S., Kongpachith, S., Tribouley, C., Graham, M., Stoll, B., Patel, M., Sahtout, M., Blaney, M., Leibman, R., Golan, T. & Tolcher, A., 2024, In: Frontiers in Oncology. 14, 1544394.Research output: Contribution to journal › Comment/debate
Open Access -
2022
Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma (Journal of Cancer Research and Clinical Oncology, (2022), 148, 7, (1703-1708), 10.1007/s00432-021-03911-0)
Margalit, O., Yu, S., Shacham-Shmueli, E., Strauss, G., Yang, Y. X., Lawrence, Y. R., Reiss, K. A., Golan, T., Halpern, N., Aderka, D., Giantonio, B., Mamtani, R. & Boursi, B., Jul 2022, In: Journal of Cancer Research and Clinical Oncology. 148, 7, p. 1709 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
2020
Erratum: The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts (Oncotarget (2019) 10 (6269-6282) DOI: 10.18632/oncotarget.27268)
Visochek, L., Atias, D., Spektor, I., Castiel, A., Golan, T. & Cohen-Armon, M., 1 Feb 2020, In: Oncotarget. 11, 5, p. 571-575 5 p.Research output: Contribution to journal › Comment/debate
Open Access -
Erratum: Exclusive destruction of mitotic spindles in human cancer cells (Oncotarget (2017) 8 (20813-20824) DOI: 10.18632/oncotarget.15343)
Visochek, L., Castiel, A., Mittelman, L., Elkin, M., Atias, D., Golan, T., Izraeli, S., Peretz, T. & Cohen-Armon, M., 1 Apr 2020, In: Oncotarget. 11, 14, p. 1290-1291 2 p.Research output: Contribution to journal › Comment/debate